Aclaris Therapeutics Stock Price. Everything You Need To Know About The Aclaris Therapeutics Stock!
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. The company is headquartered in Wayne, Pennsylvania and currently employs 105 full-time employees. The company went IPO on 2015-10-07. The firm is engaged in developing a pipeline of drug candidates to address the needs of patients with immuno-inflammatory diseases. The firm has a multi-stage portfolio of drug candidates powered by a robust research and development (R&D) engine exploring protein kinase regulation. The firm operates through two segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. The contract research segment includes provision of laboratory services. The firm is also engaged in identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize its novel drug candidates.
Aclaris Therapeutics Stock Price. Everything You Need To Know About The Aclaris Therapeutics Stock! performance
- Employees 105
- Company HQ Wayne
- Website https://www.aclaristx.com/
- ACRS Asset Type Common Stock
- ACRS Market Capitalization 86.2M
- Earnings Per Share -1.27
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Aclaris Therapeutics is an innovative biopharmaceutical company that focuses on developing and commercializing novel treatments for dermatological conditions. As a retail investor from Malaysia, Thailand, Indonesia, or Vietnam, you have the opportunity to invest in this promising stock through Zorion’s investment platform. With its cutting-edge research and development pipeline, Aclaris Therapeutics aims to address unmet medical needs and provide effective solutions for patients worldwide. By investing in Aclaris Therapeutics, you can be a part of transforming the dermatology industry and potentially benefit from its growth. Zorion offers investment insights and recommendations specifically tailored to retail investors from Malaysia, Thailand, Indonesia, and Vietnam. Our platform provides you with comprehensive resources and educational materials to enhance your understanding of investing in stocks like Aclaris Therapeutics. Take advantage of Zorion’s platform and invest in Aclaris Therapeutics today to potentially see your investments grow in the ever-evolving world of biopharmaceuticals. Start making informed investment decisions and expand your investment knowledge with Zorion.
